Thamara Melo

Dr. Thamara Melo


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
MBMirla Fontes de Araújo Borges
Mirla Fontes de Araújo Borges
RLRoosveni de Sousa Lacerda
Roosveni de Sousa Lacerda
JCJásny Pintor de Assis Correia
Jásny Pintor de Assis Correia
TMThamara Melo
Thamara Melo
SFSávio Ferreira
Sávio Ferreira
The indiscriminate use of antibiotics generates several problems for human health, the main one being bacterial resistance. The abuse of antibiotics is responsible for reducing the effectiveness of medicines, making it difficult to treat diseases and representing a major obstacle for researchers and health professionals. Natural alternatives have been widely studied, such as essential oils and their phyto-constituents, in order to verify their antibacterial action. This research aimed to identify the antibacterial activity of α-pinene. This is a descriptive study, using a qualitative approach, with methodological experience based on an integrative review. The bibliographic survey was carried out in the LILACS and MEDLINE, though the Virtual Health Library, PubMed and Web of Science databases, using the following search strategies: Anti-bacterial agents AND α-pinene for the PubMed and VHL databases, and (Antibacterial agents AND pinene) and (Antimicrobial AND α-pinene) on the Web of Science. After reading the articles in full, 10 works were selected. α-pinene was relatable, including its positive mix and its association with antimicrobials. The article points out that α-pinene has wide potential in antimicrobial therapy in order to inhibit the growth of bacteria as an isolated result or as a synergist of antibiotics. However, they are bactericidal and bacteriostatic when against bacterial strains. Therefore, it is concluded that it is relevant to develop scientific research to analyze the effectiveness of this compound to the most diverse microorganisms that affect human health.

31 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
HNHermes Diniz Neto
Hermes Diniz Neto
PFPedro Figueiredo
Pedro Figueiredo
HSHelivaldo Souza
Helivaldo Souza
Aleson Pereira de SousaAleson Pereira de Sousa
Aleson Pereira de Sousa
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Klebsiella pneumoniae causes a wide range of community and nosocomial infections. The high capacity of this pathogen to acquire resistance drugs makes it necessary to develop therapeutic alternatives, discovering new antibacterial molecules. Acetamides are molecules that have several biological activities. However, there are no reports on the activity of 2-chloro-N-(4-fluoro-3-nitrophenyl)acetamide. Based on this, this study aimed to investigate the in vitro antibacterial activity of this molecule on K. pneumoniae, evaluating whether the presence of the chloro atom improves this effect. Then, analyzing its antibacterial action more thoroughly, as well as its cytotoxic and pharmacokinetic profile, in order to contribute to future studies for the viability of a new antibacterial drug. It was shown that the substance has good potential against K. pneumoniae and the chloro atom is responsible for improving this activity, stabilizing the molecule in the target enzyme at the site. The substance possibly acts on penicillin-binding protein, promoting cell lysis. The analysis of cytotoxicity and mutagenicity shows favorable results for future in vivo toxicological tests to be carried out, with the aim of investigating the potential of this molecule. In addition, the substance showed an excellent pharmacokinetic profile, indicating good parameters for oral use.

15 June 2022 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
HAHÉLIDA MARAVILHA DANTAS E SOUSA ALMEIDA
HÉLIDA MARAVILHA DANTAS E SOUSA ALMEIDA
LBLara Bianca Soares Brandão
Lara Bianca Soares Brandão
TMThamara Melo
Thamara Melo
SFSávio Ferreira
Sávio Ferreira
The scope of this paper is to provide a state of the art in pharmacological repositioning, envisioning the antibacterial activity of non-antibiotic drugs. The method of the narrative literature review was adopted. The investigation took place during the months of January and February 2022 in electronic databases such as Medline, PubMed, VHL, and MDPI. Studies in Portuguese, English, and Spanish were included. The results reveal that several classes of drugs have antibiotic activity both in vitro and in vivo, such as the antihypertensive drug amlodipine, psychomodulators such as fluoxetine and thioridazine, and anti-inflammatory drugs such as ibuprofen. However, not everyone has an elucidated hypothesis of the reason for such an effect. Some of the mechanisms pointed out by the consulted authors were damage to the cell wall, modification of the permeability of porin proteins, and the inhibition of sliding hairpins that act with DNA polymerase. A synergistic effect was also identified. In conclusion, the antibacterial potential of pharmacological redirection is promising, with emphasis on anti-inflammatory, psychotropic, and cardiovascular intervention drugs. There is a need to deepen investigations on the mechanisms of action of the compounds already investigated, suggesting that the research of phases II and III be developed, as well as investigations of other pharmacological classes little explored.

9 November 2017
Verified
Conference Paper
Open access
SFSávio Ferreira
Sávio Ferreira
TDTassiana Dantas
Tassiana Dantas
DSDaniele Silva
Daniele Silva
TMThamara Melo
Thamara Melo
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Human mycoses have controversial treatment, since the available antifungal drugs besides favoring the appearance of resistant isolates, can present great toxicity to the human organism. This fact has driven the search for more efficient, safe and natural therapeutic alternatives with the objective of reversing this scenario of resistance presented by pathogenic fungi, for this, new natural and effective alternatives, such as the use of plant extracts, natural compounds and semi-synthetic, have been extensively investigated for the development of new drugs. In view of this scenario, this study aims to evaluate the antifungal activity of isoeugenol in vitro against strains of Penicillium citrinum. For this, the broth microdilution technique was used to determine the Minimum Inhibitory Concentration (MIC) and Minimum Fungicide Concentration (MFC) of isoeugenol and voriconazole. The concentrations by which the strains were submitted, 1024 μg/mL to 0.5 μg/mL, were obtained by means of serial dilution at a ratio of two, so that in the first row of the plate is the highest concentration and in the last , the lowest concentration. Finally, 10 μL of the fungal inoculum of each isolate was added to the wells, where each strain was placed on a plate column. MIC was defined as the lowest concentration capable of inhibiting fungal growth visually verified by maintaining the original coloration of the medium. After reading the MIC, aliquots of 20 μL of the supernatant from the wells where complete inhibition of fungal growth in the microdilution plates were observed were plated on Sabouraud dextrose agar plates. Plates were incubated, and MFC was considered the lowest concentration at which growth was less than 3 colonies. The assays were performed in triplicate and the geometric mean was calculated. The CIM of isoeugenol varied between 256 and 32 μg/mL, being the highest MIC value for the LM-21 strain and the lowest value for the LM-02, LM-03, LM-08, LM-155, LM- 157 and LM-161. The MIC range of voriconazole was 0.5 to 256 μg/mL. The MFC of isoeugenol varied between 64-512 μg/mL and for voriconazole it was 2 μg/mL and above 1024 μg/mL. In this way, we can conclude that isoeugenol presented an antifungal effect, which enables it as a potential antifungal drug, requiring complementary tests that clarify the mechanism of action involved in its antimicrobial activity.